Board and Committees

Board of Directors
Data Advisory Committee
Ethics Advisory Committee
Scientific Advisory Committee
Audit and Risk Committee
Communication and Education Committee
Finance and Administrative Committee
Chairperson:
Deputy Chairperson:
Non-official Director:
Official Director:
Chairperson

Mr Philip TSAI Wing-​chung

BBS, JP

Mr Tsai is a former Chairman of Deloitte China and has more than 35 years of experience in planning and managing audits for Hong Kong based operations of multinational groups, as well as local and overseas listed clients in a wide range of industries.

 

In addition to being a Fellow of the Hong Kong Institute of Certified Public Accountants (the “HKICPA”), the Association of Chartered Certified Accountants and the Institute of Chartered Accountants of England and Wales (the “ICAEW”), Mr Tsai is actively involved in the development of the CPA profession and also contributes his efforts in various government, community and social services.

 

Mr Tsai is a Past President of the HKICPA, a Council Member of the ICAEW, the Chairman of M Plus Collections Ltd under the West Kowloon Cultural District Authority, a Member of the Hospital Authority, the Chairman of the Hospital Governing Committee of the Queen Mary Hospital and Tsan Yuk Hospital, the Chairman of the Supplementary Medical Professions Council of the Health Bureau (formerly the Food and Health Bureau), a Member of the Advisory Committee and Audit Committee of the Mandatory Provident Fund Schemes, an Advisor of The Ombudsman, Hong Kong, a Member of the Registration Committee of the Chinese Gold and Silver Exchange, a Member of the Standing Committee on Disciplined Service Salaries and Conditions of Services of the Civil Service Bureau and a Member of the Independent Commission on Remuneration for Members of the Executive Council and the Legislature, and Officials under the Political Appointment System of the HKSAR Government.

 

Moreover, Mr Tsai is a Member of the University Grants Committee, an Adjunct Professor of the City University of Hong Kong, a Honorary Court Member, the Chairman of the Student Residence Management Board of the Hong Kong Baptist University, the Deputy Chairman of the Alumni Committee of The Hong Kong Baptist University Foundation, a Trustee of the Staff Superannuation Scheme of The Chinese University of Hong Kong and a Member of the Institutional Advancement and Outreach Committee of the University Council of The Hong Kong University of Science and Technology.

 

Mr Tsai is also the Chairperson of Hong Kong Red Cross.

Deputy Chairperson

Professor Raymond LIANG Hin-suen

SBS, JP

Professor Liang is a Specialist in Haematology and Haematological Oncology. He is currently Head of Department of Medicine, Director of Comprehensive Oncology Centre and Assistant Medical Superintendent of Hong Kong Sanatorium and Hospital. He is also Emeritus Professor of The University of Hong Kong (HKU) and Honorary Professor of both HKU and The Chinese University of Hong Kong.

 

Professor Liang was a member of the Hospital Authority Board. Furthermore, he was the Ex-Dean of Li Ka Shing Faulty of Medicine, HKU, and the Past President of the Hong Kong Academy of Medicine.

 

Professor Liang was one of the founders of Hong Kong Blood Cancer Foundation and Hong Kong Marrow Match Foundation. The latter was responsible for establishing the first all Chinese Unrelated Marrow Donor Registry, serving Chinese patients in need of bone marrow transplantation in Hong Kong, Macau, Taiwan and Mainland China, as well as Chinese patients around the world.

Non-official Director

Dr Derrick AU Kit-sing

Dr Au is the Clinical Professional Consultant (Honorary) and Centre Advisor of the Centre for Bioethics at The Chinese University of Hong Kong (CUHK). He received medical education at Brown University in the US and postgraduate training in geriatric medicine in Hong Kong. Dr Au has served in clinical service in geriatrics and rehabilitation for two decades before taking up various management positions in the Hospital Authority (HA), including Director of Quality & Safety, overseeing clinical ethics, research ethics, patient risk management and technology assessment among other responsibilities. Currently, he is Chairman of the Bioethics Course Committee in CUHK Faculty of Medicine and Chairman of the HA Clinical Ethics Committee. Dr Au is also a writer and columnist with publications on bioethics, professional ethics, and history of medicine.

Non-official Director

Dr LO Su-vui (Chief Executive Officer, Hong Kong Genome Institute)

Dr Lo was appointed as the Chief Executive Officer of Hong Kong Genome Institute (HKGI) in November 2020.  As the CEO, Dr Lo leads HKGI in formulating its strategic direction and development plan.  He also provides leadership to the team in launching the Hong Kong Genome Project, the city’s first-ever large-scale whole genome sequencing initiative.  With the aspiration to benefit the wider community, Dr Lo drives the team to be the change agent in fostering clinical application of genomic medicine and its long-term development in Hong Kong.

 

Dr Lo is a seasoned professional in public health and administrative medicine, bringing with him a wealth of knowledge in public healthcare system, service provision and relevant policies.  He also has a strong blend of experience in corporate affairs, strategic planning, talent development, research and so on.  Prior to his current role, Dr Lo had served in the Hospital Authority (HA) for over 20 years during which he had held various senior management positions, including Director of Strategy & Planning in the HA Head Office and Cluster Chief Executive of the New Territories East Cluster.

 

In addition to his extensive experience with the HA, Dr Lo also held a number of senior positions both locally and overseas.  These included being the Head of Research Office in the former Food and Health Bureau (currently the Health Bureau) of the HKSAR Government, and the Director of Purchasing (Specialist Care Services) with the Cardiff Health Authority of the National Health Service in the United Kingdom.

 

Professionally, Dr Lo is a practitioner in Public Health & Administrative Medicine. He had served as a Part I and II examiner of the Faculty of Public Health, and Censor and examiner of the Royal Australasian College of Medical Administrators.

Non-official Director

Mr Ray CHAN Chin-ching

Mr Chan is the Chief Executive Officer and co-founder of 9GAG, a global multi-platform community for viral content and interests. Founded in 2008, 9GAG’s mission is to make the world happier.

 

9GAG has a global audience of 200 million, including 56 million followers on Instagram, 42 million followers on Facebook, and 16 million followers on Twitter.

 

Mr Chan graduated from The University of Hong Kong with a degree in Law.

Non-official Director

Professor CHAN Wai-yee

Professor Chan is the Pro-Vice-Chancellor/Vice President and Li Ka Shing Professor of Biomedical Sciences at The Chinese University of Hong Kong (CUHK). He obtained his BSc (Hon. 1st Class) in Chemistry from CUHK in 1974 and PhD in Biochemistry from the University of Florida in 1977.

 

In June 2009, Professor Chan established CUHK’s School of Biomedical Sciences and served as the Founding Director and Chair Professor of Biomedical Sciences. He was appointed Pro-Vice-Chancellor/Vice President of CUHK in August 2018.

 

Professor Chan is very active in the scientific community, both locally and internationally. He has served as President of the Association of Chinese Geneticists in America and a Member of the Development Committee of the Society for the Study of Reproduction in the US. Besides being a Director of the Board of the Hong Kong Genome Institute, he is also the President of Hong Kong Institution of Science, Council Member of the Shaw Prize Foundation, a Member of the Hospital Authority, a Specialist for the Hong Kong Council for Accreditation of Academic and Vocational Qualifications, and a Member of the Board of Directors of Joshua Hellmann Foundation for Orphan Diseases.

Non-official Director

Ms Ivy CHEUNG Wing-han

Ms Cheung is the Managing Partner and the Head of Audit of KPMG Hong Kong. She is the Past President of the Hong Kong Institute of Certified Public Accountants. She currently serves as member in a number of public service committees, including the Independent Commission on Remuneration for Members of the District Councils of the HKSAR, the Standing Committee on Disciplined Services Salaries and Conditions of the Service and the Transport Advisory Committee. Apart from being a member of the Honorary Advisory Panel and the Inspection Committee of the Financial Reporting Council, she is the Director of the Hong Kong Cyberport Management Company Limited.

 

Ms Cheung has served as Member of the Air Transport Licensing Authority, the Financial Reporting Review Panel, the Non-local Higher and Professional Education Appeal Board, the Occupation Retirement Schemes Appeal Board and the Securities and Futures Appeals Tribunal.

Non-official Director

Dr CHUNG Kin-lai

Dr Chung is currently the Director of Quality and Safety of the Hospital Authority (HA). Under his leaderships, the Quality & Safety Division oversees the quality standards, patient safety, clinical incident management, patient relations management, healthcare technology assessment, disasters response and infection control for the public hospitals under HA.

 

Dr Chung is a Specialist in Emergency Medicine. Prior to his current appointment, he has been the Hospital Chief Executive of North District Hospital from 2016 to 2018, Chief Manager at HA Head Office from 2012 to 2016 and the Hospital Chief Executive of Castle Peak Hospital from 2008 to 2012.

Non-official Director

Professor Nancy IP Yuk-yu

BBS, MH, JP

Professor Ip is currently The Morningside Professor of Life Science and the Director of the State Key Laboratory of Molecular Neuroscience at The Hong Kong University of Science and Technology (HKUST). She received her PhD degree in Pharmacology from Harvard University, after which she held the position of Senior Staff Scientist at Regeneron Pharmaceuticals Inc. in New York. Since joining HKUST in 1993, she has served as the Vice-President for Research and Development, Dean of Science, Director of the Biotechnology Research Institute, and Head of the Department of Biochemistry.

 

Professor Ip is world-renowned for her significant contributions to the field of neuroscience. Her outstanding research has resulted in 324 scientific papers and 70 patents. She has been elected to the Chinese Academy of Sciences, the US National Academy of Sciences, the American Academy of Arts and Sciences, the Hong Kong Academy of Sciences, and received numerous awards and honours including the National Natural Science Awards, the L’OREAL-UNESCO for Women in Science Award and the 10 Science Stars of China by Nature. She currently serves as a Member of the Leadership Group of the Davos Alzheimer’s Collaborative, and was also an elected Councilor for the Society for Neuroscience and the Senior Editor of the Journal of Neuroscience.

Non-official Director

Dr Shawn LEUNG Shui-on

Dr Leung is the founder, Chairman and Chief Executive Officer of SinoMab BioScience Limited. Currently, he is also a Member of the Biotech Advisory Panel of The Stock Exchange of Hong Kong Limited.

 

Dr Leung has over 30 years of experience in the field of molecular immunology and therapeutic monoclonal antibodies. He was the first scientist who successfully developed humanised anti-CD22 antibody and introduced the concept of “Functional Humanisation”. He held positions as an Executive Director of a US leading antibody-drug conjugate company, the Managing Director of The Hong Kong Institute of Biotechnology Limited, and Adjunct Professor at Fudan University, The Army Medical University (formerly known as the Third Military Medical University) and The Air Force Medical University (formerly known as the Fourth Military Medical University) in Mainland China, as well as The Chinese University of Hong Kong (CUHK) and The Hong Kong University of Science and Technology.

 

Dr Leung obtained his bachelor’s and master’s degrees in biochemistry, as well as EMBA from CUHK. He earned his D.Phil. in molecular biology from the University of Oxford in the UK in May 1989. He was also a postdoctoral fellow at Yale University in the US from July 1990 to June 1992.

Non-official Director

Professor LAU Chak-sing

JP

Professor Lau is Daniel CK Yu Professor in Rheumatology and Clinical Immunology of the Li Ka Shing Faculty of Medicine at The University of Hong Kong (HKU).

 

Professor Lau graduated with MBChB from the University of Dundee in 1985. In 1992, he joined HKU as Lecturer in Medicine and successfully rose through the ranks to his current position as Chair and Daniel CK Yu Professor in Rheumatology and Clinical Immunology.

 

Professor Lau has been a major player in rheumatology in Hong Kong and beyond. Locally, he was President of the Hong Kong Society of Rheumatology (1997 – 2001) and Founding Chairman of the Hong Kong Arthritis & Rheumatism Foundation (2001). He was also the President of the Hong Kong Academy of Medicine (2016 – 2020), a statutory accrediting body for medical and dental specialist training in Hong Kong. Besides its academic role, the Academy is an entrusted advisor to the HKSAR Government on multiple health-related policies. In addition, Professor Lau sits on numerous strategic committees/working groups of the Health Bureau (formerly the Food and Health Bureau), Hospital Authority and Department of Health.

 

Regionally, Professor Lau was President of the Asia Pacific League of Rheumatology Associations (2006 – 2008) and co-founder of the multi-national, multi-centre Asia Pacific Lupus Collaboration.

 

Beyond the Asia Pacific region, he is a Member of the Outcomes in Rheumatology, European League Against Rheumatism (EULAR) Scientific Committee and EULAR Task Force on Rheumatoid Arthritis Treatment Recommendations.

Non-official Director

Dr Isabella LIU Fang-chun

Dr Liu is the Head of Baker McKenzie’s Asia Pacific Intellectual Property (IP) and Technology Group. She advises clients on matters relating to the creation, exploitation and protection of IP rights. She is also responsible for the local IP Group’s China and Hong Kong patent prosecution matters. Previously, Dr Liu was the Head of the Firm’s Asia Pacific Healthcare and Life Sciences Industry Group for three years, leading a team of legal experts in this field cross multiple practices in the region.

 

Dr Liu is ranked as a leading lawyer in her field by top legal directories such as Chambers Asia Pacific for the Life Sciences category and IAM Patent. She has been complimented by clients that she possesses “a superb ability to understand the most complex technologies” and was noted for “advis[ing] in a way that is very commercial and strategic.”

Non-official Director

Professor Dennis LO Yuk-ming

SBS, JP

Professor Lo is the Li Ka Shing Professor of Medicine of The Chinese University of Hong Kong. His research interests focus on the biology and diagnostic applications of cell-free nucleic acids in plasma. In particular, he discovered the presence of cell-free fetal DNA in maternal plasma in 1997 and has since then been pioneering non-invasive prenatal diagnosis using this technology. This technology has been adopted globally and has created a paradigm in prenatal medicine. He has also made many innovations using circulating nucleic acids for cancer detection, including the screening of early stage nasopharyngeal cancer.

 

In recognition of his research, Professor Lo has been elected as Fellow of the Royal Society, Foreign Associate of the US National Academy of Sciences, Fellow of The World Academy of Sciences and Founding Member of the Academy of Sciences of Hong Kong. He has won numerous awards, including the 2016 Future Science Prize in Life Science, the 2014 King Faisal International Prize in Medicine, the 2019 Fudan-Zhongzhi Science Award and the 2021 Breakthrough Prize in Life Sciences.

Non-official Director

Professor Alfonso NGAN Hing-wan

Professor Ngan is currently Kingboard Professor in Materials Engineering and Chair Professor of Materials Science and Engineering at The University of Hong Kong (HKU). He previously held administrative positions including Senior Advisor in the President’s Office, Acting Pro-Vice Chancellor (Research), Head of Department of Mechanical Engineering and Associate Dean of Engineering. He obtained his BSc(Eng) degree from HKU in 1989, and PhD from the University of Birmingham in the UK in 1992. After a year of postdoctoral training at the University of Oxford, he joined HKU in 1993, and was promoted through the ranks to Chair Professorship in 2011.

 

Professor Ngan’s interest includes novel stimuli-responsive materials, material defects and their modelling, and nanomechanics including applications to biological systems. His research-related honours include the Rosenhain Medal from the Institute of Materials, Minerals and Mining in the UK, DSc from the University of Birmingham, Croucher Senior Research Fellowship, International Fellow of the Royal Academy of Engineering (FREng), Fellow of the Hong Kong Academy of Engineering Sciences (FHKEng), and Guanghua Engineering Science and Technology Prize. He is currently Honorary Secretary of the Hong Kong Academy of Engineering Sciences, and is serving in a number of advisory/management boards in the HKSAR Government.

Non-official Director

Mr Tim PANG Hung-cheong

Mr Pang is a registered social worker dedicated in protecting and advocating patient’s rights. He works as Community Organizer in Society for Community Organization. He has been a Member of the Hospital Authority (HA) Review Steering Committee, a Member of the Patient Focus Group of the Hospital Accreditation Project under HA, and a Member of the Committee on Promoting Acceptance of People Living with HIV/AIDS under Hong Kong Advisory Council on AIDs.

 

Mr Pang is now a Member of the Working Group on Implementation of Modified Referral System for Physiotherapy Services under the Physiotherapists Board, and a Member of the Working Group on eHRSS Partnership under the Steering Committee on Electronic Health Record Sharing.

Non-official Director

Professor YIU Siu-ming

Professor Yiu is currently a professor and one of the Associate Heads at the Department of Computer Science of The University of Hong Kong (HKU). He is also the Director of the Department’s FinTech and Blockchain Laboratory and the Deputy Executive Director of HKU–Standard Chartered Hong Kong FinTech Academy. He was selected three times by Clarivate Analytics as one of the Highly Cited Researchers in the world in 2016, 2017 and 2019, and one of the top 1% researchers in HKU for 11 consecutive years (2011 – 2021).

 

Professor Yiu’s research areas include bioinformatics, cybersecurity, privacy technology, and FinTech. In the areas of bioinformatics, he served as the conference chair in Hong Kong for RECOMB 2017, one of the flag-ship conferences in the field and as the area programme chair for other prestigious bioinformatics conferences such as ISMB. In addition to academic research, Professor Yiu has been a consultant to various companies in the areas of cybersecurity and data privacy.

Official Director

Under Secretary for Health

Official Director

Deputy Secretary for Health

Official Director

Deputy Director of Health

Convenor: Professor YIU Siu-ming
Non-official Members: Professor Andrew CHAN Man-lok
Professor CHAN Ting-fung
Dr Chris CHAN Tsun-leung
Dr CHEUNG Ngai-tseung
Dr Lucas HUI Chi-kwong
Professor JIANG Pei-yong
Professor Terrence LAU Chi-kong
Dr Shawn LEUNG Shui-on
Dr Isabella LIU Fang-chun
Professor LUO Qiong
Professor Ian WONG Chi-kei
Professor YANG Wan-ling
Official Member: Representative from the Health Bureau
Convenor: Dr Derrick AU Kit-sing
Non-official Members: Dr Josephine CHONG Shuk-ching
Dr Calvin HO Wai-loon
Professor Stephen LAM Tak-sum
Professor LEUNG Suet-yi
Mr Tim PANG Hung-cheong
Dr Mary TANG Hoi-yin
Mr Stephen WONG Kai-yi
Mr James YIP Shiu-Kwong
Official Members: Representative from the Health Bureau
Representative from the Department of Health
Convenor: Professor Dennis LO Yuk-ming, SBS, JP
Non-official Members: Professor Godfrey CHAN Chi-fung
Dr Gladys KWAN Wai-man
Professor LAU Chak-sing, JP
Dr Danny LEUNG Chi-yeu
Professor LEUNG Tak-yeung
Dr Edmond MA Shiu-kwan
Professor Tony MOK Shu-kam
Professor SHAM Pak-chung, JP
Professor Michael YANG Mengsu
Official Members: Representative from the Health Bureau
Representative from the Department of Health
Convenor: Dr Isabella LIU Fang-chun
Non-official Members: Dr KAM Pok-man, BBS
Mrs Lesley WONG CHUI Yue-chue, SBS
Official Member: Representative from the Health Bureau
Convenor: Mr Ray CHAN Chin-ching
Non-official Members: Mr Stephen CHUNG Chun-kit
Dr Wendy LAM Wing-tak
Mr Tim PANG Hung-cheong
Ms Leona WONG Nga-lai
Official Member: Representative from the Health Bureau
Convenor: Ms Ivy CHEUNG Wing-han
Non-official Members: Mr Andrew FUNG Hau-chung, BBS, JP
Mr LAI Kam-tong
Ms Adelaide YU Hoi-man
Official Member: Representative from the Health Bureau